This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
3.L von Seidlein , A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Medicine 2006; 3: 353.
5.MM Rahaman , An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. Journal of Infectious Diseases 1975; 132: 15–19.
7.HL DuPont , Inoculum size in shigellosis and implications for expected mode of transmission. Journal of Infectious Diseases 1989; 159: 1126–1128.
8.OS Levine , MM Levine . Houseflies (Musca domestica) as mechanical vectors of shigellosis. Review of Infectious Diseases 1991; 13: 688–696.
9.Anon. Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994? Goma Epidemiology Group. Lancet 1995; 345: 339–344.
11.JC Mohle-Boetani , Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers. American Journal of Public Health 1995; 85: 812–816.
12.ML Bennish , BJ Wojtyniak . Mortality due to shigellosis: community and hospital data. Review of Infectious Diseases 1991; 13 (Suppl. 4): 245–251.
13.F Koster , Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. New England Journal of Medicine 1978; 298: 927–933.
15.HC Chao , Bacterial enteric infections in children: etiology, clinical manifestations and antimicrobial therapy. Expert Review of Anti-Infective Therapy 2006; 4: 629–638.
16.JA Finkelstein , Antimicrobial use in defined populations of infants and young children. Archives of Pediatrics & Adolescent Medicine 2000; 154: 395–400.
17.R Jain , LH Danziger . The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview. Current Pharmaceutical Design 2004; 10: 3045–3053.
18.S Sivapalasingam , High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrobial Agents and Chemotherapy 2006; 50: 49–54.
20.AV Jennison , NK Verma . Shigella flexneri infection: pathogenesis and vaccine development. FEMS Microbiology Reviews 2004; 28: 43–58.
22.A Phalipon , LA Mulard , PJ Sansonetti . Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path? Microbes and Infection 2008; 10: 1057–1062.
24.R Pack , Willingness to be vaccinated against shigella and other forms of dysentery: a comparison of three regions in Asia. Vaccine 2006; 24: 485–494.
29.X Chen , Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China. Vaccine 2006; 24: 561–571.
34.P Streefland , AM Chowdhury , P Ramos-Jimenez . Patterns of vaccination acceptance. Social Science and Medicine 1999; 49: 1705–1716.
37.K Jamil , The immunization programme in Bangladesh: impressive gains in coverage, but gaps remain. Health Policy Plan 1999; 14: 49–58.
42.W Checkley , Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community. Lancet 2004; 363: 112–118.
44.Anon. Water and sanitation: the neglected health MDG. Lancet 2006; 368: 1212.